TABLE 3

HCF Admissions and Serious Medical Outcomes Associated With Exposure to Each Type of Prescription Opioid by Age Group, NPDS 2000–2015

Admission to an HCF, n (%)Serious Medical Outcome, n (%)
Type of Opioid0–5 Yearsa6–12 Yearsa13–19 YearsaTotalb0–5 Yearsa6–12 Yearsa13–19 YearsaTotalb
Buprenorphine2589 (51.0)57 (32.8)70 (13.8)2716 (47.1)1127 (22.2)24 (13.8)102 (20.0)1253 (21.7)
Methadone1269 (36.6)124 (23.3)716 (32.3)2109 (33.9)761 (22.0)73 (13.7)712 (32.1)1546 (24.9)
Oxymorphone50 (27.3)4 (18.2)44 (33.3)98 (29.1)21 (11.5)1 (4.5)48 (36.4)70 (20.8)
Fentanyl38 (17.1)1 (3.6)57 (35.0)96 (23.2)29 (13.1)2 (7.1)90 (55.2)121 (29.3)
Morphine817 (21.6)75 (13.0)365 (18.9)1257 (20.0)361 (9.5)50 (8.7)316 (16.4)727 (11.6)
Hydromorphone60 (18.2)6 (8.0)32 (24.8)98 (18.4)30 (9.1)3 (4.0)16 (12.4)49 (9.2)
Tramadol555 (4.5)90 (5.1)2244 (31.5)2889 (13.6)227 (1.8)66 (3.7)1795 (25.2)2088 (9.8)
Propoxyphene122 (2.1)22 (2.9)919 (27.3)1063 (10.7)28 (0.5)14 (1.9)328 (9.8)370 (3.7)
Oxycodone1342 (6.7)139 (4.3)1568 (15.7)3049 (9.2)746 (3.7)104 (3.2)957 (9.6)1807 (5.4)
Meperidine37 (8.8)9 (6.1)28 (11.9)74 (9.2)18 (4.3)8 (5.4)23 (9.7)49 (6.1)
Hydrocodone424 (1.5)99 (1.8)3760 (19.3)4283 (7.9)223 (0.8)74 (1.4)1291 (6.6)1588 (2.9)
Codeine269 (1.4)80 (1.6)1395 (20.1)1744 (5.6)164 (0.9)108 (2.1)502 (7.2)774 (2.5)
Other2252 (18.0)88 (4.5)893 (21.8)3233 (17.4)1197 (9.6)53 (2.7)689 (16.8)1939 (10.4)
Total9824 (8.7)794 (4.0)12 091 (21.5)22 709 (12.0)4932 (4.4)580 (2.9)6869 (12.2)12 381 (6.6)
  • a Percentages were calculated by using the total number of exposures for each type of prescription opioid within each age group.

  • b Percentages were calculated by using the total number of exposures for each type of prescription opioid.